Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

VERTEX PHARMACEUTICALS

(VRTX)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur VERTEX PHARMACEUTICALS
03/12PUMP / DUMP #13 : This week's gainers and losers
01/12Equities Led Higher Midday by Energy, Financials Following BioNTech CEO Comment on Vacc..
01/12Electrocomponents und Dechra Pharma kommen in FTSE 100
01/12MIDDAY REPORT : US Stocks Led Higher by Energy, Financials Following BionTech CEO Comment ..
01/12Vertex Pharmaceuticals Up Over 7%, Best Performer in The S&P 500 and Nasdaq 100 So Far ..
01/12Vertex's Kidney Disorder Drug VX-147 Reduces Proteinuria in Phase 2 Study
01/12Vertex Pharmaceuticals to Advance VX-147 Kidney Drug After Phase 2 Study
01/12Vertex Announces Positive Results From Phase 2 Study of VX-147 in APOL1-Mediated Focal ..
01/12Vertex Pharmaceuticals Incorporated Announces Positive Results From Phase 2 Study of VX..
22/11NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
22/11Vertex Announces Reimbursement Agreement in Spain for KAFTRIO (ivacaftor/tezacaftor/ele..
19/11Vertex Pharmaceuticals' Combination Therapy for Cystic Fibrosis Gets Spanish Approval f..
19/11Vertex Announces Reimbursement Agreement in Spain for KAFTRIO® (ivacaftor/tezacaftor/el..
18/11Novartis Said Considering Takeover in Biotech Sector
12/11Vertex Pharmaceuticals Receives Positive Opinion on Cystic Fibrosis Treatment in Childr..
12/11Vertex Cystic Fibrosis Treatment Gets CHMP Backing in Patients Ages 6-11
12/11Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) i..
12/11Vertex Pharmaceuticals Incorporated Receives CHMP Positive Opinion for Kaftrio(Ivacafto..
11/11Tres valores para terminar el año
09/11Arbor Biotechnologies, Inc. announced that it has received $215 million in funding from..
03/11VERTEX PHARMACEUTICALS INC / MA Management's Discussion and Analysis of Financial Cond..
03/11Tranche Update on Vertex Pharmaceuticals Incorporated's Equity Buyback Plan announced o..
03/11Vertex Pharmaceuticals' Q3 Results Underline Competitive Position in Cystic Fibrosis, O..
02/11Q3 2021 Presentation
02/11VERTEX : Q3 Earnings Snapshot
02/11Vertex Pharmaceuticals Q3 Results Rise; Lifts 2021 Product Revenue Guidance
02/11Broad pipeline advancing with recent progress marked by unprecedented VX-880 clinical r..
02/11Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Posts Q3 EPS $3.56, vs. Stree..
02/11Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q3 Revenue $1.98B, vs..
02/11Vertex Reports Third-Quarter 2021 Financial Results
02/11Vertex Pharmaceuticals Incorporated Reports Earnings Results for the Third Quarter and ..
02/11Vertex Pharmaceuticals Incorporated Revises Revenue Guidance for the Year 2021
02/11EARNINGS REACTION HISTORY : Vertex Pharmaceuticals, 50.0% Follow-Through Indicator, 2.6% S..
29/10Arbor Biotechnologies, Inc. announced that it expects to receive $214.999926 million in..
27/10Health Canada Accepts Vertex's New Drug Submission Supplement For Trikafta For Cystic F..
27/10Vertex's Supplement to a New Drug Submission for TRIKAFTA® (elexacaftor/tezacaftor/ivac..
27/10Vertex Pharmaceuticals Incorporated's Supplement to a New Drug Submission for TRIKAFTA?..
26/10Vertex, Mammoth Biosciences to Develop In Vivo Gene-Editing Therapies for Genetic Disea..
26/10Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing T..
26/10Vertex and Mammoth Biosciences Announce Collaboration to Develop in Vivo Gene-Editing T..
25/10VERTEX PHARMACEUTICALS : to Announce Third-Quarter 2021 Financial Results on November 2
22/10VERTEX PHARMACEUTICALS : to Announce Third-Quarter 2021 Financial Results on November 2
20/10TRACKINSIGHT : Cathie’s ARK fleet sails to green waters
19/10VERTEX PHARMACEUTICALS : to Present Long-Term Data Demonstrating Significant Benefits of T..
19/10Vertex to Present Long-Term Data Demonstrating Significant Benefits of Treatment With C..
18/10VERTEX PHARMACEUTICALS : Reports 'Unprecedented' Results From Trial of VX-880 to Treat Typ..
18/10MOLECULAR TEMPLATES : Vertex Terminates Collaboration
18/10VERTEX PHARMACEUTICALS : Announces Positive Day 90 Data for the First Patient in the Phase..
18/10Molecular Templates, Inc. Receives Notice from Vertex Pharmaceuticals Incorporated to T..
18/10Vertex Pharmaceuticals Incorporated Announces Positive Day 90 Data for the First Patien..
15/10Analysis-Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
15/10Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
22/09VERTEX PHARMACEUTICALS' : Kalydeco Drug Submission Accepted for Priority Review by Health ..
22/09VERTEX PHARMACEUTICALS : Supplement to a New Drug Submission for KALYDECO® (ivacaftor) for..
22/09Vertex Pharmaceuticals Incorporated Announces Its Supplement to a New Drug Submission f..
17/09VERTEX PHARMACEUTICALS : Announces Letter of Intent With pan-Canadian Pharmaceutical Allia..
17/09Vertex Pharmaceuticals Incorporated Letter of Intent with Pan-Canadian Pharmaceutical A..
15/09Vertex Pharmaceuticals Incorporated Provides Earnings Guidance for the Year 2021
14/09VERTEX PHARMACEUTICALS : to Present at the Morgan Stanley Virtual 19th Annual Global Healt..
13/09VERTEX PHARMACEUTICALS : to Present at the Morgan Stanley Virtual 19th Annual Global Healt..
10/09NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
09/09A step closer to tapering
09/09ANALYST RECOMMENDATIONS : Boohoo, Boston Beer, Cisco Systems, Eversource, Frontline...
09/09Obsidian Therapeutics, Inc. announced that it has received $114.999999 million in fundi..
08/09NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
07/09AKTIEN IM FOKUS : US-Pharmawerte nach Abstufungen durch Morgan Stanley schwach
26/08VERTEX PHARMACEUTICALS : Announces Publication in The New England Journal of Medicine of P..
26/08Vertex Pharmaceuticals Incorporated Announces Publication in The New England Journal of..
25/08VERTEX PHARMACEUTICALS : Health Canada Grants Marketing Authorization for KALYDECO® (ivaca..
25/08Vertex Pharma Gets Approval for Cystic Fibrosis Drug for Infants in Canada
24/08VERTEX PHARMACEUTICALS : and Arbor Biotechnologies Establish New Partnership to Develop No..
24/08VERTEX PHARMACEUTICALS : Teams With Arbor to Develop Cell Therapies for Treatment of Major..
24/08Vertex Pharmaceuticals Incorporated and Arbor Biotechnologies Establish New Partnership..
19/08Obsidian Therapeutics, Inc. announced that it expects to receive $115.043755 million in..
06/08VERTEX PHARMACEUTICALS : Significant Insider Buying Reverses Sale Trend of Last 90 Days in..
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur VERTEX PHARMACEUTICALS